Literature DB >> 7980639

Effect of different oxygen pressures and N,N'-diphenyl-p-phenylenediamine on Adriamycin toxicity to cultured neonatal rat heart myocytes.

K Ollinger1, A Brunmark.   

Abstract

The effect of different oxygen pressures and the antioxidant DPPD (N,N'-diphenyl-p-phenylenediamine) on Adriamycin (doxorubicin) cytotoxicity in highly purified cardiac myocytes was investigated to evaluate the involvement of free radicals in the mechanism of toxicity. Adriamycin exposure caused a time-dependent decrease in viability measured as intracellular potassium ion release or lactate dehydrogenase retention. Incubation of myocytes in 16, 172 or 834 microM oxygen during exposure to 200 microM Adriamycin for 6 hr killed 13, 42 and 56% of the cells in the respective cultures. DPPD prolonged viability in the latter two oxygen concentrations and protected against lipid peroxidation measured as production of malondialdehyde and 4-hydroxynonenal. Addition of superoxide dismutase decreased the Adriamycin-induced cell killing to 6% after a 4-hr incubation, as compared to 24% in cultures exposed to Adriamycin only. Adriamycin exposure decreased the concentration of reduced glutathione, and the toxicity of the drug was increased when glutathione reductase was inhibited by the addition of BCNU (1,3-bis-2-chloroethyl-1-nitrosourea). No significant effect on Adriamycin toxicity was observed after inhibition of glutathione synthesis by treatment with BSO (buthionine sulfoximine). It is concluded that free radicals play an important role in Adriamycin toxicity to heart myocytes, and that the cell killing mechanism is likely to be related to induction of lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980639     DOI: 10.1016/0006-2952(94)90455-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes.

Authors:  K Roberg; K Ollinger
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  Chromium Therapy for Insulin Resistance Associated with HIV-Disease.

Authors:  Seth A Stein; Margaret Mc Nurlan; Brett T Phillips; Catherine Messina; Dennis Mynarcik; Marie Gelato
Journal:  J AIDS Clin Res       Date:  2013-09-07

3.  Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal.

Authors:  S Srivastava; A Chandra; N H Ansari; S K Srivastava; A Bhatnagar
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

4.  Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal.

Authors:  J Renes; E E de Vries; G J Hooiveld; I Krikken; P L Jansen; M Müller
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.